Association between Sacubitril/Valsartan Initiation and Health Status Outcomes in Heart Failure with Reduced Ejection Fraction

OBJECTIVE: Our objective is to describe the short-term, health status benefits of ARNI initiation in patients with heart failure and reduced ejection fraction (HFrEF). BACKGROUND: While sacubitril/valsartan, a neprilysin inhibitor (ARNI), improved patients’ health status (compared with enalapril) at...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:JACC Heart Fail
Auteurs principaux: Khariton, Yevgeniy, Fonarow, Gregg C., Arnold, Suzanne V., Hellkamp, Ann, Nassif, Michael E., Sharma, Puza P., Butler, Javed, Thomas, Laine, Duffy, Carol I, DeVore, Adam, Albert, Nancy M., Patterson, J. Herbert, Williams, Fredonia B., McCague, Kevin, Spertus, John A.
Format: Artigo
Langue:Inglês
Publié: 2019
Sujets:
Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7122134/
https://ncbi.nlm.nih.gov/pubmed/31521679
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jchf.2019.05.016
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires